Publications 2021

Fosen JT (2021)
Ethyl glucuronide in hair and nail as a biomarker of alcohol consumption
University of Oslo
PublikaID 412, ISBN 978-82-8377-852-6

Publications 2020

Fosen JT, Morland J, Hoiseth G (2020)
The Relationship Between Ingested Dose of Ethanol and Amount of Ethyl Glucuronide Formed in Blood
J. Anal. Toxicol., 44 (8), 861-863
DOI 10.1093/jat/bkaa090

Publications 2019

Fosen JT, Hoiseth G, Sempio C, Giarratana N, Enger A, Morland J, Morini L (2019)
Hair EtG: Alterations in segment levels accompanying hair growth
Drug Test. Anal., 11 (1), 112-118
DOI 10.1002/dta.2474

Publications 2017

Fosen JT, Morini L, Sempio C, Giarratana N, Enger A, Morland J, Hoiseth G (2017)
Ethyl Glucuronide Elimination Kinetics in Fingernails and Comparison to Levels in Hair
Alcohol Alcohol., 52 (5), 580-586
DOI 10.1093/alcalc/agx035

Publications 2016

Bjanes TK, Hjerto EM, Lonne L, Aronsen L, Berg JA, Bergan S, Berg-Hansen GO, Bernard JP, Burns ML, Fosen JT, Frost J, Hilberg T, Krabseth HM, Kvan E, Narum S, Westin AA (2016)
Pharmacology Portal: An Open Database for Clinical Pharmacologic Laboratory Services
Clin. Ther., 38 (1), 222-226
DOI 10.1016/j.clinthera.2015.10.015

Fosen JT, Morini L, Sempio C, Ganss R, Morland J, Hoiseth G (2016)
Levels of Hair Ethyl Glucuronide in Patients with Decreased Kidney Function: Possibility of Misclassification of Social Drinkers
Alcoholism (NY), 40 (3), 451-456
DOI 10.1111/acer.12970

Publications 2015

Hoiseth G, Fosen JT, Liane V, Bogstrand ST, Morland J (2015)
Alcohol Hangover as a Cause of Impairment in Apprehended Drivers
Traffic Inj. Prev., 16 (4), 323-328
DOI 10.1080/15389588.2014.938324

Publications 2014

Karinen R, Fosen JT, Rogde S, Vindenes V (2014)
An accidental poisoning with mitragynine
Forensic Sci.Int., 245, E29-E32
DOI 10.1016/j.forsciint.2014.10.025

Publications 2011

Kringen MK, Haug KBF, Grimholt RM, Stormo C, Narum S, Opdal MS, Fosen JT, Piehler AP, Johansen PW, Seljeflot I, Berg JP, Brors O (2011)
Genetic Variation of VKORC1 and CYP4F2 Genes Related to Warfarin Maintenance Dose in Patients with Myocardial Infarction
J. Biomed. Biotechnol., 739751
DOI 10.1155/2011/739751